Use of antidepressant medications and risk of fracture in older women

Calcified Tissue International

Volumn 88, Issue 6, 2011, Pages 476-484

  Diem, Susan J ^a   Blackwell, Terri L ^b   Stone, Katie L ^b   Cauley, Jane A ^c   Hillier, Teresa A ^d   Haney, Elizabeth M ^e   Ensrud, Kristine E ^a,f  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d KAISER PERMANENTE   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antidepressant; Depression; Fracture; Population study; Selective serotonin reuptake inhibitor; Tricyclic antidepressant

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE;

AGE DISTRIBUTION; AGED; ARTICLE; BONE DENSITY; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; FRACTURE; GERIATRIC PATIENT; HIP FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT DURATION; WRIST FRACTURE;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BONE DENSITY; COHORT STUDIES; FEMALE; FRACTURES, BONE; HUMANS; INTERVIEWS AS TOPIC; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS;

EID: 79959689792     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-011-9481-5     Document Type: Article

References (56)

1. Bolton JM, Metge C, Lix L et al (2008) Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol 28:384-391
2. Ensrud KE, Blackwell T, Mangione CM et al (2003) Central nervous system active medications and risk for fractures in older women. Arch Intern Med 163:949-957
3. Ginzburg R, Rosero E (2009) Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants. Ann Pharmacother 43:98-103
4. Hubbard R, Farrington P, Smith C et al (2003) Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture. Am J Epidemiol 158:77-84 (Pubitemid 36745333)
5. Lewis CE, Ewing SK, Taylor BC et al (2007) Predictors of nonspine fracture in elderly men: the MrOS study. J Bone Miner Res 22:211-219 (Pubitemid 46167791)
6. Liu B, Anderson G, Mittmann N et al (1998) Use of selective serotonin-reuptake inhibitors of tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351:1303-1307 (Pubitemid 28195906)
7. Richards JB, Papaioannou A, Adachi JD et al (2007) Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167:188-194 (Pubitemid 46148067)
8. Schneeweiss S, Wang PS (2004) Association between SSRI use and hip fractures and the effect of residual confounding bias in claims database studies. J Clin Psychopharmacol 24:632-638 (Pubitemid 39518660)
9. Vestergaard P, Rejnmark L, Mosekilde L (2006) Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int 17:807-816 (Pubitemid 43781493)
10. Vestergaard P, Rejnmark L, Mosekilde L (2008) Selective serotonin reuptake inhibitors and other antidepressants and risk of fracture. Calcif Tissue Int 82:92-101
11. Ziere G, Dieleman JP, van der Cammen TJ et al (2008) Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J Clin Psychopharmacol 28:411-417
12. van den Brand MW, Samson MM, Pouwels S et al (2009) Use of antidepressants and the risk of fracture of the hip or femur. Osteoporos Int 20:1705-1713
13. Ray WA (1992) Psychotropic drugs and injuries among the elderly: a review. J Clin Psychopharmacol 12:386-396
14. Thapa PB, Gideon P, Cost TW et al (1998) Antidepressants and the risk of falls among nursing home residents. N Engl J Med 339:875-882 (Pubitemid 28446845)
15. Ruthazer R, Lipsitz LA (1993) Antidepressants and falls among elderly people in long-term care. Am J Public Health 83:746-749 (Pubitemid 23143011)
16. Diem SJ, Blackwell TL, Stone KL et al (2007) Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch Intern Med 167:1240-1245
17. Haney EM, Chan BK, Diem SJ et al (2007) Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 167:1246-1251 (Pubitemid 46998495)
18. Warden SJ, Robling AG, Sanders MS et al (2005) Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 146:685-693 (Pubitemid 40129824)
19. Haney EM, Warden SJ, Bliziotes MM (2010) Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management? Bone 46:13-17
20. Warden SJ, Robling AG, Haney EM et al (2010) The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5). Bone 46:4-12
21. Diem SJ, Blackwell TL, Stone KL et al (2007) Depressive symptoms and rates of bone loss at the hip in older women. J Am Geriatr Soc 55:824-831
22. Eskandari F, Martinez PE, Torvik S et al (2007) Low bone mass in premenopausal women with depression. Arch Intern Med 167:2329-2336 (Pubitemid 350179528)
23. Jacka FN, Pasco JA, Henry MJ et al (2005) Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study. Menopause 12:88-91 (Pubitemid 40204898)
24. Mezuk B, Eaton WW, Golden SH et al (2008) Depression, antidepressants, and bone mineral density in a population-based cohort. J Gerontol A Biol Sci Med Sci 63:1410-1415
25. Michelson D, Stratakis C, Hill L et al (1996) Bone mineral density in women with depression. N Engl J Med 335:1176-1181 (Pubitemid 26339771)
26. Milliken LA, Wilhelmy J, Martin CJ et al (2006) Depressive symptoms and changes in body weight exert independent and site-specific effects on bone in postmenopausal women exercising for 1 year. J Gerontol A Biol Sci Med Sci 61:488-494 (Pubitemid 43794708)
27. Robbins J, Hirsch C, Whitmer R et al (2001) The association of bone mineral density and depression in an older population. J Am Geriatr Soc 49:732-736 (Pubitemid 32652465)
28. Schweiger U, Weber B, Deuschle M et al (2000) Lumbar bone mineral density in patients with major depression: evidence of increased bone loss at follow-up. Am J Psychiatry 157:118-120 (Pubitemid 30027431)
29. Sogaard AJ, Joakimsen RM, Tverdal A et al (2005) Long-term mental distress, bone mineral density and non-vertebral fractures. The Tromso Study. Osteoporos Int 16:887-897 (Pubitemid 41127097)
30. Whooley MA, Kip KE, Cauley JA et al (1999) Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159:484-490 (Pubitemid 29108914)
31. Whooley MA, Cauley JA, Zmuda JM et al (2004) Depressive symptoms and bone mineral density in older men. J Geriatr Psychiatry Neurol 17:88-92 (Pubitemid 38720313)
32. Wong SY, Lau EM, Lynn H et al (2005) Depression and bone mineral density: is there a relationship in elderly Asian men? Results from Mr. Os (Hong Kong). Osteoporos Int 16:610-615 (Pubitemid 40897457)
33. Yazici KM, Akinci A, Sutcu A et al (2003) Bone mineral density in premenopausal women with major depressive disorder. Psychiatry Res 117:271-275 (Pubitemid 36398502)
34. Coelho R, Silva C, Maia A et al (1999) Bone mineral density and depression: a community study in women. J Psychosom Res 46:29-35 (Pubitemid 29030507)
35. Mussolino ME (2005) Depression and hip fracture risk: the NHANES I epidemiologic follow-up study. Public Health Rep 120:71-75
36. Cummings SR, Black DM, Nevitt MC et al (1990) Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA 263:665-668 (Pubitemid 20042530)
37. Pahor M, Chrischilles EA, Guralnik JM et al (1994) Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 10:405-411 (Pubitemid 24339205)
38. Ensrud KE, Palermo L, Black DM et al (1995) Hip and calcaneal bone loss increase with advancing age: longitudinal results from the study of osteoporotic fractures. J Bone Miner Res 10:1778-1787
39. Steiger P, Cummings SR, Black DM et al (1992) Age-related decrements in bone mineral density in women over 65. J Bone Miner Res 7:625-632
40. Sheikh JI, Yesavage JA (1986) Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 5:165-173 (Pubitemid 17221439)
41. Gerety MB, Williams JW Jr, Mulrow CD et al (1994) Performance of case-finding tools for depression in the nursing home: influence of clinical and functional characteristics and selection of optimal threshold scores. J Am Geriatr Soc 42:1103-1109 (Pubitemid 24309823)
42. Ensrud KE, Nevitt MC, Yunis C et al (1994) Correlates of impaired function in older women. J Am Geriatr Soc 42:481-489 (Pubitemid 24145298)
43. Fitti JE, Kovar MG (1987) The supplement on aging to the 1984 National Health Interview Survey. Vital Health Stat 1:1-115
44. Pincus T, Summey JA, Soraci SA Jr et al (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26:1346-1353 (Pubitemid 14231480)
45. Folstein MF, Robins LN, Helzer JE (1983) The mini-mental state examination. Arch Gen Psychiatry 40:812
46. Ensrud KE, Walczak TS, Blackwell T et al (2004) Antiepileptic drug use increases rates of bone loss in older women: a prospective study. Neurology 62:2051-2057 (Pubitemid 38738220)
47. Spangler L, Scholes D, Brunner RL et al (2008) Depressive symptoms, bone loss, and fractures in postmenopausal women. J Gen Intern Med 23:567-574
48. Bliziotes MM, Eshleman AJ, Zhang XW et al (2001) Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake. Bone 29:477-486 (Pubitemid 33026469)
49. Battaglino R, Fu J, Spate U et al (2004) Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res 19:1420-1431 (Pubitemid 41094343)
50. Bliziotes M, Eshleman A, Burt-Pichat B et al (2006) Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. Bone 39:1313-1321 (Pubitemid 44827920)
51. Bonnet N, Bernard P, Beaupied H et al (2007) Various effects of antidepressant drugs on bone microarchitecture, mechanical properties and bone remodeling. Toxicol Appl Pharmacol 221:111-118 (Pubitemid 46711209)
52. Warden SJ, Haney EM (2008) Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from in vitro and animal-based studies. J Musculoskelet Neuronal Interact 8:121-132
53. Warden SJ, Nelson IR, Fuchs RK et al (2008) Serotonin (5-hydroxytryptamine) transporter inhibition causes bone loss in adult mice independently of estrogen deficiency. Menopause 15:1176-1183
54. Battaglino R, Vokes M, Schulze-Spate U et al (2007) Fluoxetine treatment increases trabecular bone formation in mice. J Cell Biochem 100:1387-1394 (Pubitemid 46515573)
55. Yadav VK, Ryu JH, Suda N et al (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135:825-837
56. Williams LJ, Henry MJ, Berk M et al (2008) Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int Clin Psychopharmacol 23:84-87 (Pubitemid 351317280)